Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02381548
Title	Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	chronic myeloid leukemia acute myeloid leukemia bone marrow cancer
Therapies	Adavosertib + Belinostat
Age Groups:	adult
Covered Countries	USA